Saccharomyces boulardii

布拉氏酵母菌

Report date: 2024/08/26 17:49:23

Base Information

Drug NameSaccharomyces boulardii
Drug Alias NameSaccharomyces boulardii capsules布拉氏酵母菌胶囊Saccharomyces boulardii sachets布拉氏酵母菌散Saccharomyces boulardii CNCM I-745 +[8] 
ClassificationNatural product/Extract > Microbial extract
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAutism Spectrum DisorderDiarrheaIrritable Bowel Syndrome
Global Approved IndicationsDiarrhea
Approved Indications in ChinaDiarrhea
Original Approved Country/TerritoryMainland China
Original Approved Date2015/10/30
Country/TerritoryPortugalEcuadorSpain +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBiocodex Sa
China Registration ClassN/A

Develop Information

Active CompaniesUniversidad San Francisco De QuitoBiocodex Sa
Inactive CompaniesN/A
Active IndicationsAutism Spectrum DisorderDiarrheaIrritable Bowel Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeA07FA
Related LinksN/A